Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission

Summary

This is a phase 0/phase I feasibility trial to test the hypothesis that flaxseed supplementation is an effective maintenance therapy for patients with ovarian cancer who are in clinical remission following platinum-based regimens. The investigators further hypothesize levels of estrogen metabolites and prostaglandin E2 in this patient population will correlate with recurrence of disease, extent of tumor burden, invasion and metastasis.

Timeline

Start

2015-03

Primary completion

2020-03

Completion

2021-03

Drugs

Indications